Alessia Poggi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alessia Poggi has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Valeria Martini
Department of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy
9 shared publications - Fulvio Riondato
Department of Veterinary Sciences, School of Agriculture and Veterinary Medicine, University of Turin
5 shared publications L. Aresu
Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Italy
5 shared publications- Maria Elena Gelain
Department of Comparative Biomedicine and Food Science, University of Padua, 35020 Legnaro, Italy
5 shared publications - Stefano Comazzi
Department of Veterinary Medicine and Animal Sciences, University of Milan, Via dell’Università 6, 26900 Lodi, Italy
5 shared publications B. Miniscalco
Department of Veterinary Sciences, University of Turin, Largo Braccini 2, Grugliasco, Turin, Italy
4 shared publications
Latest Publications
- 1 May 2018
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 161, 34-42
Flow Cytometric Characterization of S-phase Fraction and Ploidy in Lymph Node Aspirates from Dogs with Lymphoma
- 1 May 2018
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 161, 34-42
Flow Cytometric Characterization of S-phase Fraction and Ploidy in Lymph Node Aspirates from Dogs with Lymphoma
- 1 December 2017
- Published by Elsevier in Research in Veterinary Science
- Vol. 115, 288-293
Identification of peripheral blood involvement in dogs with large B-cell lymphoma: Comparison of different methods
- 1 December 2017
- Published by Elsevier in Research in Veterinary Science
- Vol. 115, 288-293
Identification of peripheral blood involvement in dogs with large B-cell lymphoma: Comparison of different methods
- 1 May 2017
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 187, 14-19
Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression
- 1 May 2017
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 187, 14-19
Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression
- 1 April 2016
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 172, 38-42
Identification of a suitable internal control for fluorescence analysis on canine peripheral blood samples
- 1 April 2016
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 172, 38-42
Identification of a suitable internal control for fluorescence analysis on canine peripheral blood samples
- 21 January 2016
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 15 (2) , 431-440
Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high‐grade B‐cell lymphoma
Ki67 can discriminate between high‐ and low‐grade canine lymphomas, but its prognostic role in specific subtypes of the neoplasm is unknown. We assessed the prognostic significance of Ki67% (percentage of Ki67‐positive cells), evaluated by flow cytometry, in 40 dogs with high‐grade B‐cell lymphoma, treated with a modified Wisconsin–Madison protocol (UW‐25). The following variables were investigated for association with lymphoma specific survival (LSS) and relapse free interval (RFI): Ki67%, breed, sex, age, stage, substage, complete remission (CR). By multivariate analysis, Ki67% (P = 0.009) and achievement ofCR(P = 0.001) were independent prognostic factors forLSS. Dogs with intermediate Ki67% (20.1–40%) presented longerLSSandRFI(median = 866 and 428 days, respectively) than dogs with low (median = 42 days,P < 0.001; median = 159 days,P = 0.014) or high (median = 173 days,P = 0.038; median = 100 days,P = 0.126) values. Determination of Ki67 is a prognostic tool that improves the clinical usefulness of flow cytometric analysis in canine high‐grade B‐cell lymphoma.
- 21 January 2016
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 15 (2) , 431-440
Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high‐grade B‐cell lymphoma
Ki67 can discriminate between high‐ and low‐grade canine lymphomas, but its prognostic role in specific subtypes of the neoplasm is unknown. We assessed the prognostic significance of Ki67% (percentage of Ki67‐positive cells), evaluated by flow cytometry, in 40 dogs with high‐grade B‐cell lymphoma, treated with a modified Wisconsin–Madison protocol (UW‐25). The following variables were investigated for association with lymphoma specific survival (LSS) and relapse free interval (RFI): Ki67%, breed, sex, age, stage, substage, complete remission (CR). By multivariate analysis, Ki67% (P = 0.009) and achievement ofCR(P = 0.001) were independent prognostic factors forLSS. Dogs with intermediate Ki67% (20.1–40%) presented longerLSSandRFI(median = 866 and 428 days, respectively) than dogs with low (median = 42 days,P < 0.001; median = 159 days,P = 0.014) or high (median = 173 days,P = 0.038; median = 100 days,P = 0.126) values. Determination of Ki67 is a prognostic tool that improves the clinical usefulness of flow cytometric analysis in canine high‐grade B‐cell lymphoma.
- Open Access
- 13 December 2015
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 90 (6) , 525-530
Analytical and diagnostic validation of a flow cytometric strategy to quantify blood and marrow infiltration in dogs with large B‐cell lymphoma
Background: Lymph node (LN), peripheral blood (PB), and bone marrow (BM) samples are commonly analyzed by flow cytometry (FC) for the immunophenotyping and staging of canine lymphomas. A prognostic value for FC BM infiltration in dogs with large B‐cell lymphoma (LBCL) was demonstrated. Aim of this study was to define the analytical performances of this technique, and to establish a cutoff suitable to safely discriminate between infiltrated and noninfiltrated PB and BM samples.Methods: Large B‐cells were added to control PB and BM samples, to achieve twelve different large B‐cells concentrations, ranging from 0 to 50%. The percentage of large B‐cells was recorded for each dilution, using a BD Accuri C6 FC. Accuracy was evaluated by Passing‐Bablok regression analysis. Intra‐assay precision was assessed at 0%, 1, 3, and 10% dilutions evaluating the CVs of 10 repeated acquisitions. ROC curves were drawn to identify the cutoffs most suitable to discriminate between 25 infiltrated (PARR‐positive) and 25 noninfiltrated (PARR‐negative) PB and BM samples, respectively.Results: Optimal analytical accuracy and precision were achieved. Almost all CVs were <10%. Negative controls had up to 0.5% large B‐cells, with 50 and 22% CV in PB and BM samples, respectively, 0.56 and 2.45% cutoffs were selected based on the ROC curves for PB and BM samples, respectively.Conclusions: Quantification of large B‐cells in PB and BM samples by FC is reliable and analytical performances met the acceptance criteria. Assessment of performances of different instruments and protocols is warranted. © 2016 International Clinical Cytometry Society
- 13 December 2015
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 90 (6) , 525-530
Open AccessAnalytical and diagnostic validation of a flow cytometric strategy to quantify blood and marrow infiltration in dogs with large B‐cell lymphoma
Background: Lymph node (LN), peripheral blood (PB), and bone marrow (BM) samples are commonly analyzed by flow cytometry (FC) for the immunophenotyping and staging of canine lymphomas. A prognostic value for FC BM infiltration in dogs with large B‐cell lymphoma (LBCL) was demonstrated. Aim of this study was to define the analytical performances of this technique, and to establish a cutoff suitable to safely discriminate between infiltrated and noninfiltrated PB and BM samples.Methods: Large B‐cells were added to control PB and BM samples, to achieve twelve different large B‐cells concentrations, ranging from 0 to 50%. The percentage of large B‐cells was recorded for each dilution, using a BD Accuri C6 FC. Accuracy was evaluated by Passing‐Bablok regression analysis. Intra‐assay precision was assessed at 0%, 1, 3, and 10% dilutions evaluating the CVs of 10 repeated acquisitions. ROC curves were drawn to identify the cutoffs most suitable to discriminate between 25 infiltrated (PARR‐positive) and 25 noninfiltrated (PARR‐negative) PB and BM samples, respectively.Results: Optimal analytical accuracy and precision were achieved. Almost all CVs were <10%. Negative controls had up to 0.5% large B‐cells, with 50 and 22% CV in PB and BM samples, respectively, 0.56 and 2.45% cutoffs were selected based on the ROC curves for PB and BM samples, respectively.Conclusions: Quantification of large B‐cells in PB and BM samples by FC is reliable and analytical performances met the acceptance criteria. Assessment of performances of different instruments and protocols is warranted. © 2016 International Clinical Cytometry Society
- 14 October 2015
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 15 (2) , 366-373
Chronic lymphocytic leukemia transformation into high‐grade lymphoma: a description of Richter's syndrome in eight dogs
Richter's syndrome (RS) is the development of an aggressive lymphoma in patients with chronic lymphocytic leukaemia (CLL). In humans,RSoccurs in 2–20% ofCLL, which transform into diffuse large B‐cell lymphoma but reports in dogs are scarce. This study retrospectively describes eight dogs withCLLprogressing intoRS. A database including 153 dogs withCLL(93TCD8+ and 55 B‐CLL) was interrogated andRSwas demonstrated in eight cases (representing 5.2% of totalCLL): two with T‐cell (2.2% of TCLL) and six with a B‐cell immunophenotype (10.9% of B‐CLL). WhenRSoccurred, lymphocytes were decreased compared toCLL. Five dogs had anaemia and two dogs thrombocytopenia. Frequent clinical signs included lymph node swelling, coughing, vomiting, neurological signs and weight loss. Independently from the therapy,RSwas associated with a short survival (median 41 days).RSshould be considered as an unfavourable evolution in canineCLL.
- 14 October 2015
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 15 (2) , 366-373
Chronic lymphocytic leukemia transformation into high‐grade lymphoma: a description of Richter's syndrome in eight dogs
Richter's syndrome (RS) is the development of an aggressive lymphoma in patients with chronic lymphocytic leukaemia (CLL). In humans,RSoccurs in 2–20% ofCLL, which transform into diffuse large B‐cell lymphoma but reports in dogs are scarce. This study retrospectively describes eight dogs withCLLprogressing intoRS. A database including 153 dogs withCLL(93TCD8+ and 55 B‐CLL) was interrogated andRSwas demonstrated in eight cases (representing 5.2% of totalCLL): two with T‐cell (2.2% of TCLL) and six with a B‐cell immunophenotype (10.9% of B‐CLL). WhenRSoccurred, lymphocytes were decreased compared toCLL. Five dogs had anaemia and two dogs thrombocytopenia. Frequent clinical signs included lymph node swelling, coughing, vomiting, neurological signs and weight loss. Independently from the therapy,RSwas associated with a short survival (median 41 days).RSshould be considered as an unfavourable evolution in canineCLL.
- 3 June 2015
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 14 (S1) , 117-126
Canine small clear cell/T‐zone lymphoma: clinical presentation and outcome in a retrospective case series
Published studies, taken together, suggest the existence of a single canine lymphoma entity, with a small clear cell appearance by cytological evaluation, a histopathological T‐zone pattern and an aberrant CD45‐negative T‐cell phenotype, mostly characterized by long‐term survival. We describe clinical presentation and outcome in a retrospective case series of canine small clear cell/T‐zone lymphoma. Despite the reported predisposition of Golden retriever, this breed was not represented in our case series. Most dogs presented with stage V disease, whereas only few had clinical signs or peripheral cytopenias. Blood was almost always more infiltrated than bone marrow. Median survival confirmed the favourable prognosis described in literature, but a few dogs died within a short time. Also, a subgroup of dogs developed second malignancies, eventually leading to death. We did not investigate possible prognostic factors because of the wide variety in treatments, and further studies are needed to identify high‐risk animals.
- 3 June 2015
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 14 (S1) , 117-126
Canine small clear cell/T‐zone lymphoma: clinical presentation and outcome in a retrospective case series
Published studies, taken together, suggest the existence of a single canine lymphoma entity, with a small clear cell appearance by cytological evaluation, a histopathological T‐zone pattern and an aberrant CD45‐negative T‐cell phenotype, mostly characterized by long‐term survival. We describe clinical presentation and outcome in a retrospective case series of canine small clear cell/T‐zone lymphoma. Despite the reported predisposition of Golden retriever, this breed was not represented in our case series. Most dogs presented with stage V disease, whereas only few had clinical signs or peripheral cytopenias. Blood was almost always more infiltrated than bone marrow. Median survival confirmed the favourable prognosis described in literature, but a few dogs died within a short time. Also, a subgroup of dogs developed second malignancies, eventually leading to death. We did not investigate possible prognostic factors because of the wide variety in treatments, and further studies are needed to identify high‐risk animals.
- Open Access
- 1 May 2014
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 159 (1-2) , 91-96
CD44 in canine leukemia: Analysis of mRNA and protein expression in peripheral blood
- 1 May 2014
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 159 (1-2) , 91-96
Open AccessCD44 in canine leukemia: Analysis of mRNA and protein expression in peripheral blood
- 17 December 2013
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 13 (4) , 475-480
Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma
Ki67 is a nuclear antigen significantly correlated with degree of malignancy in human non‐Hodgkin lymphomas. We wanted to assess the ability of flow cytometric evaluation of Ki67 index (Ki67I) in differentiating the grade of malignancy in canine lymphomas. Ki67I was determined on lymph node aspirates of 90 immunophenotyped lymphomas classified according to the updated Kiel classification: 80 high grade (HG, 62 B cell and 18 T cell) and 10 low grade (LG, 3 B cell and 7 T cell) lymphomas. HG lymphomas showed significantly higher Ki67I compared with LG lymphomas (P < 0.0001). A significant difference in HG lymphomas was detected between B‐ and T‐immunophenotypes. Receiver operating characteristic (ROC) curve highlighted a high accuracy of Ki67I in recognizing HG lymphomas [area under the curve (AUC) = 99.4] and a cut‐off value of 12.2% was established (sensitivity = 96.3% and specificity = 100%). Thus, we suggest the combination of Ki67I flow cytometric determination and immunophenotype as a reliable tool to classify canine lymphomas.
- 17 December 2013
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 13 (4) , 475-480
Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma
Ki67 is a nuclear antigen significantly correlated with degree of malignancy in human non‐Hodgkin lymphomas. We wanted to assess the ability of flow cytometric evaluation of Ki67 index (Ki67I) in differentiating the grade of malignancy in canine lymphomas. Ki67I was determined on lymph node aspirates of 90 immunophenotyped lymphomas classified according to the updated Kiel classification: 80 high grade (HG, 62 B cell and 18 T cell) and 10 low grade (LG, 3 B cell and 7 T cell) lymphomas. HG lymphomas showed significantly higher Ki67I compared with LG lymphomas (P < 0.0001). A significant difference in HG lymphomas was detected between B‐ and T‐immunophenotypes. Receiver operating characteristic (ROC) curve highlighted a high accuracy of Ki67I in recognizing HG lymphomas [area under the curve (AUC) = 99.4] and a cut‐off value of 12.2% was established (sensitivity = 96.3% and specificity = 100%). Thus, we suggest the combination of Ki67I flow cytometric determination and immunophenotype as a reliable tool to classify canine lymphomas.